Immunophenotypic analysis in 119 patients with acute myeloid leukemia following a previous malignancy: A comparison with the immunophenotype of 231 de novo cases

Haematologica

Volumn 88, Issue 2, 2003, Pages 225-227

  Pagano, Livio ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

Immunophenotype; Secondary acute myeloid leukemia

Indexed keywords

ACUTE GRANULOCYTIC LEUKEMIA; ADOLESCENT; ADULT; AGED; ARTICLE; CANCER SURVIVAL; FEMALE; HUMAN; IMMUNOPHENOTYPING; KARYOTYPE; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PROGNOSIS; SECOND CANCER; SURVIVAL TIME; ACUTE DISEASE; COMPARATIVE STUDY; LETTER; MIDDLE AGED; MYELOID LEUKEMIA; PATHOLOGY;

BIOLOGICAL MARKER; LEUKOCYTE ANTIGEN;

ACUTE DISEASE; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD; BIOLOGICAL MARKERS; FEMALE; HUMANS; IMMUNOPHENOTYPING; LEUKEMIA, MYELOID; MALE; MIDDLE AGED; NEOPLASMS, SECOND PRIMARY; PROGNOSIS;

EID: 0038284062     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Legrand O, Perrot JY, Baudard M, Cordier A, Lautier R, Simonin G, et al. The immunophenotype of 177 adults with acute myeloid leukemia: proposal of a prognostic score. Blood 2000;96:870-7.
2. Del Poeta G, Stasi R, Venditti A, Suppo G, Aronica G, Bruno A, et al. Prognostic value of cell marker analysis in de novo acute myeloid leukemia. Leukemia 1994;8:388-94.
3. de Nully Brown P, Jurlander J, Pedersen-Bjergaard J, Victor MA, Geisler CH. The prognostic significance of chromosomal analysis and immunophenotyping in 117 patients with de novo acute myeloid leukemia. Leuk Rese 1997;21:985-95.
4. Bradstock K, Matthews J, Benson E, Page F, Bishop J. Prognostic value of immunophenotyping in acute myeloid leukemia. Blood, 1994;84:1220-5.
5. Kanda Y, Hamaki T, Yamamoto R, Chizuka A, Suguro M, Matsuyama T, et al. The clinical significance of CD34 expression in response to therapy of patients with acute myeloid leukemia. Cancer 2000;88:2529-33.
6. Casasnovas RO, Campos L, Mugneret F, Charrin C, Bené MC, Garand R, et al. Immunophenotypic patterns and cytogenetic anomalies in acute non-lymploblastic leukemia subtypes: a prospective study of 432 patients. Leukemia 1998;12:34-43.
7. Venditti A, Del Poeta G, Buccisano F, Tamburini A, Cox-Froncillo MC, Aronica G, et al. Prognostic relevance of the expression of Tdt and CD7 in 335 cases of acute myeloid leukemia. Leukemia 1998;12:1056-63.
8. Khalidi HS, Chang KL, Medeiros U, Brynes RK, Slovak ML, Murata-Collins JL, et al. Acute lymphoblastic leukemia. Survey of immunophenotype, French-American-British classification, frequency of myeloid antigen expression, and karyotypic abnormalities in 210 pediatric and adult cases. Am J Clin Pathol 1999;111:467-76.
9. +/DR phenotypes with shorter survival. Groupe d'Etude Immunologique des Leucemies (GEIL). Leukemia 1992;6:393-9.
10. Lima M, Texeira M dos A, Morais S, Cunha M, Coutinho J, Pinho L, et al. Immunophenotypic characteristics of acute leukaemia after myelodysplastic syndromes. Sangre 1995;40:49-52.
11. Grimwade D, Walker H, Oliver F, Wheatley K, Harrison C, Harrison G, et al. The importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children's Leukaemia Working Parties. Blood 1998;92:2322-33.